Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Avastin saga reveals debate over clinical trial endpoints.

× No keyword cloud information.

6 in total

Review 1. Is Participation in Cancer Phase I Trials Really Therapeutic?

Authors: Jonathan Kimmelman
Journal: J Clin Oncol Date: 2016-09-30 Impact factor: 44.544

Review 2. Strategies for improving the clinical benefit of antiangiogenic drug based therapies for breast cancer.

Authors: Robert S Kerbel
Journal: J Mammary Gland Biol Neoplasia Date: 2012-09-26 Impact factor: 2.673

3. Anti-Bv8 antibody and metronomic gemcitabine improve pancreatic adenocarcinoma treatment outcome following weekly gemcitabine therapy.

Authors: Erez Hasnis; Dror Alishekevitz; Svetlana Gingis-Veltski; Rotem Bril; Ella Fremder; Tali Voloshin; Ziv Raviv; Amir Karban; Yuval Shaked
Journal: Neoplasia Date: 2014-06-20 Impact factor: 5.715

Review 4. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.

Authors: Laurel B Darragh; Ayman J Oweida; Sana D Karam
Journal: Front Immunol Date: 2019-01-31 Impact factor: 7.561

Review 5. Bevacizumab Addition in Neoadjuvant Treatment Increases the Pathological Complete Response Rates in Patients with HER-2 Negative Breast Cancer Especially Triple Negative Breast Cancer: A Meta-Analysis.

Authors: Xuelei Ma; Xiaoshan Wang; Jingwen Huang; Yingtai Chen; Jing Zhang; Binglan Zhang; Changle Shi; Lei Liu
Journal: PLoS One Date: 2016-08-31 Impact factor: 3.240

6. Optimizing the treatment of bevacizumab as first-line therapy for human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer: an updated meta-analysis of published randomized trials.

Authors: Cunfu Li; Aizhai Xiang; Xianzhi Chen; Kai Yin; Jinsong Lu; Wenjin Yin
Journal: Onco Targets Ther Date: 2017-06-27 Impact factor: 4.147

6 in total